Target intelligence / Profile preview

Neuronal lipid microdomain (LR)

Target
LR
Molecular classification
Membrane microdomain, Other
01

Overview

Neuronal lipid microdomains, or lipid rafts, are specialized, dynamic regions of the neuronal plasma membrane enriched in cholesterol and sphingolipids that serve as platforms for signal transduction and protein trafficking (Pike, 2006, J Lipid Res). These domains organize critical neuronal proteins, including neurotransmitter receptors and ion channels, thereby regulating synaptic plasticity and neurotransmission (Siawrys et al., 2022, IJMS). In neurodegenerative diseases like Alzheimer's, lipid rafts are the primary sites for the amyloidogenic processing of amyloid precursor protein (APP) by beta- and gamma-secretases, facilitating the production of neurotoxic amyloid-beta (Simons & Gerl, 2010, Nat Rev Mol Cell Biol). They also play a role in the aggregation of alpha-synuclein and the propagation of prions (Michel & Bakovic, 2007, FEBS J). Pharmacological strategies targeting these microdomains often involve modulating lipid levels, such as using statins to deplete cholesterol or omega-3 fatty acids to alter membrane fluidity and protein clustering (Siawrys et al., 2022, IJMS). However, the lack of specificity for neuronal versus systemic membranes presents a significant therapeutic challenge, as disrupting these fundamental structures can interfere with essential cellular signaling (Simons & Gerl, 2010, Nat Rev Mol Cell Biol).

Other names
Lipid raftsMembrane raftsDetergent-resistant membranesCholesterol-rich microdomainsNeuronal lipid raftsNeuronal membranes
02

Mechanism of action

Modulation of membrane lipid composition, cholesterol depletion, and disruption of protein-lipid scaffolding to alter signaling and proteolytic processing.

03

Biological functions

Signal transductionSynaptic plasticityProtein traffickingEndocytosisNeurotransmitter receptor organizationOther
04

Disease associations

Neurodegenerative diseaseAlzheimer's diseaseParkinson's diseasePrion diseaseInfectionOther
05

Safety considerations

Lack of cell-type specificityDisruption of essential homeostatic signalingPotential systemic lipid metabolism interferenceAlteration of blood-brain barrier integrity
06

Interacting drugs

Atorvastatin

6 more in the full profile.

07

Biomarkers

Flotillin-1Caveolin-1GM1 gangliosideCholesterol

Beyond the preview

Go deeper on Neuronal lipid microdomain (LR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal lipid microdomain (LR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call